Anticoagulant and platelet-antiaggregating therapy in stroke and threatened stroke.
The author presents studies suggesting that anticoagulants are not indicated in completed stroke except when it is caused by an embolus from a well-defined cardiac source. Preferred and alternate treatment and therapy for stroke and threatened stroke is discussed.
D000925:Anticoagulants / Q000627:therapeutic use*; D001241:Aspirin / Q000627:therapeutic use; D002544:Cerebral Infarction / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000209:etiology; D002561:Cerebrovascular Disorders / Q000188:drug therapy* / Q000401:mortality; D002986:Clinical Trials as Topic; D003327:Coronary Disease / Q000150:complications; D006801:Humans; D002546:Ischemic Attack, Transient / Q000188:drug therapy; D010974:Platelet Aggregation / Q000187:drug effects; D011897:Random Allocation; D012306:Risk; D012723:Sex; D014057:Tomography, X-Ray Computed
D000925:Anticoagulants; D001241:Aspirin